Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker

Tech Insider : Business
Red pills with $100 bills wrapped around them.
Chris Roop, head of M&A for the Americas at investment bank Jefferies, said Big Pharma will be looking for new drugs to boost growth in 2025.

GP Kidd/Getty Images

Widely Used Inhalers Won't Cost More Than $35 a Month, AstraZeneca Says

Gizmodo

AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1.

AstraZeneca Requests FDA Approval for Self-Administered Nasal Flu Vaccine

Gizmodo

AstraZeneca submitted a request for the FDA on Wednesday to approve a self-administered nasal flu vaccine for people ages two to 49 years old.

Subscribe to astrazeneca